permission and has approved the allocate of newly issued ordinary shares for offering to the private placement and request for waiver from the requirement to make a tender offer for all of the company's

Company based on the assumption that the rights under the warrants are exercised in full and ACO I will become a majority shareholder of the Company with a direct shareholding of 17.84 percent of the total

issued ordinary shares to accommodate the adjustment of rights for the warrants of the Company based on the assumption that the rights under the warrants are exercised in full and ACO I will become a

can vary based on the position, work experience, role and responsibility, year of working with the Company, competency, current and previous performance, also the potential and prospect that each

exchange and laws on public limited companies. The Company may offer to sell shares at a price higher than the registered value, provided that the Company shall allocate all proceeds in excess of the value

the laws on securities and exchange and laws on public limited companies. The Company may offer to sell shares at a price higher than the registered value, provided that the Company shall allocate all

) (337.23) (27.73) (13,204.76) Based on the performance of DCORP from the consolidated financial statements of the first quarter of the year 2019 ended March 31, 2019, the Company had total revenue of THB

(loss) for the period (113.79) (1,491.35) (197.67) (38,758.82) Profit (Loss) attributable to owners of the Company (113.79) (1,491.35) (197.35) (38,696.08) Based on the performance of DCORP from the

under CPN’s book compared to GLAND’s book, which are based on its original cost. Non-recurring item CPN has non-recurring items during 2019 compared to the previous year as follows: • In 2Q19, CPN

(172.69) (899.90) (274.97) (45,077.05) Profit (Loss) attributable to owners of the Company (172.69) (899.90) (274.97) (45,077.05) Based on the performance of DCORP from the consolidated financial statements